Microfluidics Market - Growth, Trends, and Forecast (2019-2024)

The Microfluidics Market is segmented by Component, Application (Drug Delivery, HTS, POC, Lab Analytics, Clinical Diagnostics), Material, and Geography

Market Snapshot

microfluidics market
Study Period:


Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Microfluidics Market

The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD 13,348.29 million in 2024, witnessing a CAGR of 18.80%. Factors that are propelling the growth of the market include rising demand for point-of-care testing, increasing Incidences of chronic diseases, faster turn-around time for analysis, and improved portability of devices.

POC testing allows healthcare experts to diagnose a patient in the physician’s office, in an ambulance, at home, field, or in the hospital. Microfluidic technology-assisted devices are being employed for POC testing, as they require small volumes of samples and use micro-fabricated channels to analyze these samples. POC testing devices are already popular in glucose, blood, hemoglobin, and HIV testing domains. Future POC testing devices are likely to focus more on antibiotics therapies and cancer.

With the wide range of applications offered by these devices, microfluidic technology-based POC testing devices have immense potential in the developing and developed countries, as the percentage of population affected by these diseases is high.

Scope of the Report

This report estimates the global microfluidics market size by summing up the value of market segments divided on the basis of type of component, application, and materials. Further, each of these segments are sub-divided to cover all relevant categories.

Microfluidic Chips
Micro Pumps
Micro Needles
Other Components
Drug Delivery
High-throughput Screening
Point-of-Care Diagnostics
Lab Analytics
Cell-based Assay
Capillary Electrophoresis
Clinical Diagnostics
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment

In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.80% during the forecast period.

A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient's blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.

So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market's growth.

microfluidics market

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to do the Same in the Forecast Period

The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R&D. Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.

microfluidics market

To understand geography trends, Download Sample Report

Competitive Landscape

The microfluidics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with affordable prices. Companies, like Danaher Corporation, PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., hold substantial shares in the market.

Major Players

  1. Danaher Corporation
  2. PerkinElmer Inc.
  3. Agilent Technologies Inc.
  4. Bio-Rad Laboratories Inc.
  5. Thermo Fischer Scientific Inc.

* Complete list of players covered available in the table of contents below

microfluidics market

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Point-of-care Testing

      2. 4.2.2 Increasing Incidences of Chronic Diseases

      3. 4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process

      2. 4.3.2 Low Adoption in Developing Countries due to High Prices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Component

      1. 5.1.1 Microfluidic Chips

      2. 5.1.2 Micro Pumps

      3. 5.1.3 Micro Needles

      4. 5.1.4 Other Components

    2. 5.2 Application

      1. 5.2.1 Drug Delivery

      2. 5.2.2 High-throughput Screening

      3. 5.2.3 Point-of-Care Diagnostics

      4. 5.2.4 Lab Analytics

        1. Proteomics

        2. Genomics

        3. Cell-based Assay

        4. Capillary Electrophoresis

      5. 5.2.5 Clinical Diagnostics

    3. 5.3 Material

      1. 5.3.1 Polymer

      2. 5.3.2 Silicone

      3. 5.3.3 Glass

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 F. Hoffmann-LA Roche Ltd

      3. 6.1.3 Agilent Technologies

      4. 6.1.4 Danaher Corporation (Cepheid)

      5. 6.1.5 Thermo Fisher Scientific Inc.

      6. 6.1.6 Bio-Rad Laboratories Inc.

      7. 6.1.7 PerkinElmer Inc.

      8. 6.1.8 FluIdigm Corporation

      9. 6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd)

      10. 6.1.10 Micronit Microfluidics

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!

Complete your payment details below

Shipping & Billing Information

Payment Information